Skip to main content

Marketing Metrics and Myopic Usage of Analytics


Most U.S. marketers are using analytics. They recognize the importance of measuring marketing effectiveness, especially when they are asked to justify their spending. However, according to a report by eMarketer, there is room for improvement in formalizing approaches and communicating results.

According to a survey of senior marketing executives by Forbes Insights and MarketShare Partners, nearly seven in ten said they used analytics to measure marketing effectiveness. Marketers with large budgets were significantly more likely to do so than those with spending of less than $1 million. But, many in that group planned to adopt analytics in the future.

Many marketers still take an informal approach to measurement. Among those with budgets over $1 million, while 85 percent said they used analytics, 71 percent said they had a formalized way of doing so.

Marketers focused most on internal resources to measure the success of their programs, with 86 percent using internal data, 74 percent relying on internal teams and 52 percent on internally developed tools.

In comparison, 58 percent used third-party data and only 35 percent employed outside professional services.

Much of this effort is directed toward justifying marketing programs, but the marketers surveyed often lacked an effective way of communicating the success of their campaigns to other executives. While three-quarters of marketers begin initiatives with clear goals set out, only 56 percent have a system for assessing the campaign's business impact.

I wonder what percentage of marketers actually use analytics reports to make ongoing changes to their marketing practices. I suspect that most companies only look at the historical data to assess past performance. Few use it for forward-looking projections, or as a basis for realigning marketing spending.

Popular posts from this blog

Digital Transformation Investment at $3.4 Trillion

Business technology leadership matters. Across the globe, more leaders have been pursuing bold Digital Transformation (DX) initiatives with the goal of creating new sources of business value through digital products, services, and experiences. As an additional benefit, the COVID-19 pandemic revealed that digital transformation efforts improve an organization's resilience against global market disruptions. Global DX investment is forecast to reach $3.4 trillion in 2026 with a five-year compound annual growth rate (CAGR) of 16.3 percent, according to the latest worldwide market study by International Data Corporation (IDC). Digital Transformation Market Development "Despite strong headwinds from global supply chain constraints, soaring inflation, political uncertainty, and an impending recession, investment in digital transformation is expected to remain robust," said Craig Simpson, senior research manager at IDC . The benefits of investing in DX technology -- including aut

Artificial Intelligence for National Border Security

National border protection agencies are under pressure to provide the highest level of security in the face of growing threats, such as increasing illegal migration and international terrorism. Now, government agencies are embracing advanced border security technologies to aid in effectively and reliably securing national borders. These solutions look to detect and identify potential threats and prevent them from escalating to a point that may jeopardize security. Security Surveillance Market Development Traditional border security patrols and Closed-circuit Television (CCTV) surveillance systems aren't adequate protection, and agencies must increasingly deploy new solutions to stay ahead of criminals and other potential threats to ensure the safety of a country’s borders. According to the latest market study by Juniper Research, the value of the border security technology market will exceed $70 billion globally in 2027 -- that's rising from $48 billion in 2022. Growing by 47 p

Precision Medicine Spend to Reach $132.3 Billion

Precision Medicine uses molecular info to extract the optimum medical method from diagnostic protocols, by merging the impact of environmental and genetic factors. Data access is essential, with genetic metabolic and clinical data used to build a fuller picture of a patient's biology. Moreover, the primary aim of precision medicine is to design and optimize a pathway for diagnosis, therapeutic intervention, and prognosis, using large biological datasets. Personalized, evidence-based medicine uses stored health data, which includes patient diagnosis, laboratory work, insurance claims, and demographic information. The results enable healthcare providers to predict and prevent some illnesses. Precision Medicine Market Development According to the latest worldwide market study by Juniper Research, the total investment in precision medicine will reach $132.3 billion globally by 2027 -- that's increasing from only $35.7 billion in 2022. The significant market growth of 270 percent is